GSK3830052 is a selective DNA methyltransferase 1 ( DNMT1 ) inhibitor. GSK3830052 can be used to study cancer , sickle cell disease, β-thalassemia, and other diseases associated with DNMT1 inhibition.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA Methyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye